A MULTICENTER STUDY OF LONG-TERM ENZYME REPLACEMENT THERAPY IN PATIENTS WITH FABRY DISEASE IN GREECE

被引：0
|
作者：
Andrikos, A. [1 ]
Iatrou, Ch. [2 ]
Boletis, J. N. [3 ]
Diamandopoulos, A. [4 ]
Pappas, M. [1 ]
Kalaitzidis, K. [5 ]
Katsinas, Ch. [6 ]
Balafa, O. [7 ]
Revela, I. [2 ]
Dimitroula, V. [3 ]
Drakoulogona, O. [4 ]
Ouzouni, A. [6 ]
Siamopoulos, K. C. [7 ]
机构：
[1] G Hatzikosta Gen Hosp, Dept Nephrol, Ioannina, Greece
[2] Gen Hosp Nikea, Dept Nephrol, Piraeus, Greece
[3] Gen Hosp Laiko Athens, Dept Nephrol, Athens, Greece
[4] Gen Hosp Agios Andreas Patras, Dept Nephrol, Patras, Greece
[5] Gen Hosp Ptolemaida, Dept Nephrol, Ptolemaida, Greece
[6] Gen Hosp Kavala, Dept Nephrol, Kavala, Greece
[7] Univ Hosp Ioannina, Dept Nephrol, Ioannina, Greece
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of enzyme replacement therapy for Fabry disease
    Wilcox, WR
    Banikazemi, M
    Guffon, N
    Waldek, S
    Lee, P
    Linthorst, GE
    Desnick, RJ
    Germain, DP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (01) : 65 - 74
  • [2] Evaluation of long-term enzyme replacement therapy for children with Fabry disease
    Hebert, Amanda
    Lacbawan, Ley
    Taber, Tabitha
    Goker-Alpan, Ozlem
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S47 - S47
  • [3] Long-term efficacy and safety of enzyme replacement therapy in Fabry disease
    Germain, DP
    Caplan, L
    Eng, CM
    Guffon, N
    Lee, P
    Linthorst, G
    Waldeck, S
    Wilcox, WR
    Desnick, RJ
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 70 - 70
  • [4] Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease
    Oder, Daniel
    Nordbeck, Peter
    Wanner, Christoph
    NEPHRON, 2016, 134 (01) : 30 - 36
  • [5] Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease
    Lenders, Malte
    Schmitz, Boris
    Stypmann, Joerg
    Duning, Thomas
    Brand, Stefan-Martin
    Kurschat, Christine
    Brand, Eva
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (12) : 2090 - 2097
  • [6] Target organ damages in patients with Fabry disease after long-term enzyme replacement therapy
    Collin, C.
    Ong, K. -T.
    Briet, M.
    Bozec, E.
    Mousseaux, E.
    Froissart, M.
    Germain, D.
    Boutouyrie, P.
    Laurent, S.
    JOURNAL OF HYPERTENSION, 2008, 26 : S420 - S420
  • [7] PREDICTORS OF LONG-TERM OUTCOME IN A SPANISH COHORT OF PATIENTS WITH FABRY DISEASE ON ENZYME REPLACEMENT THERAPY
    Goicoechea, Marian
    Gomez-Preciado, Francisco
    Benito, Silvia
    Torras, Joan
    Torra, Roser
    Huerta, Ana
    Restrepo, Alejandra
    Ugalde, Jessica
    Astudillo, Daniela
    Agraz, Irene
    Lopez-Mendoza, Manuel
    De Arriba, Gabriel
    Corchete, Elena
    Quiroga, Borja
    Luisa Martin-Conde, Maria
    Jose Gutierrez, Maria
    Lopes, Vanessa
    Ramos, Carmela
    Mendez, Irene
    Cao, Mercedes
    Dominguez, Fernando
    Ortiz, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 363 - 363
  • [8] Successful long-term enzyme replacement therapy in a young adult with Fabry disease
    Kampmann, C.
    Kalkum, G.
    Beck, M.
    Whybra, C.
    CLINICAL GENETICS, 2013, 83 (04) : 395 - 396
  • [9] Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease
    Montorsi, F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (07) : 995 - 996
  • [10] Long term enzyme replacement therapy for Fabry disease.
    Wilcox, WR
    Banikazemi, M
    Guffon, N
    Lee, P
    Linthorst, GE
    Waldek, S
    Germain, DP
    Desnick, RJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 624 - 624
12345